Monday November 9 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«GenVec

Below is an extended GenVec patents listing. Click here to return to the GenVec main Biocorporate entry.

GenVec Patents :

US Patent No.Title
5965358 Method for assessing the relative purity of viral gene transfer vector stocks
6391612 Vectors, cells, and methods for the production of deleterious adenoviral, herpes viral and adeno-associated viral vectors
6440728 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus
6440944 Methods of administering adenoviral vectors
6447995 Utilizing intrinsic fluorescence to detect adenovirus
6455314 Alternatively targeted adenovirus
6458578 Recombinant cell line produces adenoviral gene products E1 and DEF-A, and/or DEF-B
6465253 Vectors and methods for gene transfer to cells
6472176 Polynucleotide encoding chimeric protein and related vector, cell, and method of expression thereof
6475757 Plasmids for construction of eukaryotic viral vectors
6482616 RCA-free adenoviral vector system and propagation method
6383795 Efficient purification of adenovirus
6329200 Plasmids for construction of eukaryotic viral vectors
6329190 Targetting adenovirus with use of constrained peptide motifs
5965541 Vectors and methods for gene transfer to cells
5994106 Stocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirus
6057155 Targeting adenovirus with use of constrained peptide motifs
6063627 Methods and vectors for site-specific recombination
6113913 Recombinant adenovirus
6127525 Chimeric adenoviral coat protein and methods of using same
6153435 Nucleic acid that encodes a chimeric adenoviral coat protein
6168941 Method of producing adenoviral vector stocks
6225113 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene in an at least E4-deficient adenovirus
6225289 Methods and compositions for preserving adenoviral vectors
6514943 Method and composition for preserving viruses
6573092 Method of preparing a eukaryotic viral vector
6821775 Viral vector encoding pigment epithelium-derived factor
6861229 Method of identifying a gene product
6908762 Method of preparing a eukaryotic viral vector
6913927 Non-adenoviral gene product-based complementing cells for adenoviral vectors
6939540 Method of enhancing bone density
6951755 Vectors and methods for gene transfer
6998263 Methods of preparing and using a viral vector library
7070930 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus
7141406 Efficient purification of adenovirus
7195896 Complementary adenoviral vector systems and cell lines
6756044 Antigenic complexes and methods
6753321 Method of modulating neovascularization
6740525 Adenoviral capsid containing chimeric protein IX
6576456 Chimeric adenovirus fiber protein
6579522 Replication deficient adenoviral TNF vector
6586226 Efficient purification of adenovirus
6596270 Methods of administering adenoviral vectors
6630299 Fluorescence detection
6649373 Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene
6649407 Targeting adenovirus with use of constrained peptide motifs
6660521 Use of trans-activation and CIS-activation to increase the persistence of a transgene in an at least E4-deficient adenovirus
6677156 Non-adenoviral gene product-based complementing cells for adenoviral vectors
6682929 Adenovector complementing cells
7214368 Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-.alpha. transgene

«GenVec

This page contained an extended GenVec patents listing. Click here to return to the GenVec main Biocorporate entry.

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.